Physician profile
Barbara A Bennett
NPI 1003819525
$16,492.26
in general payments reported to CMS, 2019-2025
67 companies · $3,851 in 2025
The $3,851 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,695 · 2020: $1,402 · 2021: $1,605 · 2022: $1,657 · 2023: $2,628 · 2024: $3,655 · 2025: $3,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,064.45 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,370.89 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $1,950.56 | 2020-2025 | Vraylar, Qulipta, Ubrelvy |
| Amgen INC. | $885.76 | 2019-2025 | Otezla, Repatha, Otezla |
| Pfizer INC. | $828.85 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $688.59 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $687.73 | 2021-2025 | |
| Dexcom, INC. | $679.08 | 2021-2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $674.51 | 2019-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $619.00 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $539.78 | 2019-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $503.39 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Otsuka America Pharmaceutical, INC. | $413.09 | 2022-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $409.45 | 2019-2023 | Spravato |
| Lilly USA, LLC | $391.48 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Amarin Pharma, INC. | $353.19 | 2019-2022 |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $348.80 | 2019-2025 | Jardiance, Spiriva Respimat, Synjardy |
| Takeda Pharmaceuticals U.S.A., INC. | $306.15 | 2019-2024 | Trintellix |
| Allergan, INC. | $294.74 | 2019-2021 | |
| Mylan Specialty L.P. | $293.98 | 2023-2024 | Yupelri |
| Biohaven Pharmaceutical Holding Company LTD. | $265.14 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $231.18 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Biohaven Pharmaceuticals, INC. | $219.05 | 2021 | |
| Merck Sharp & Dohme LLC | $205.46 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $189.60 | 2025 | Caplyta |
| Abbott Laboratories | $169.10 | 2020-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $158.61 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lundbeck LLC | $138.32 | 2020-2025 | Rexulti |
| Almatica Pharma LLC | $127.34 | 2023-2024 | Gralise, Teriparatide, Loreev Xr |
| Novartis Pharmaceuticals Corporation | $119.81 | 2020-2025 | |
| Axsome Therapeutics, INC. | $107.76 | 2025 | Symbravo, Sunosi |
| Sumitomo Pharma America, INC. | $95.46 | 2023-2025 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $77.62 | 2024-2025 | Voquezna |
| Viatris Specialty LLC | $74.61 | 2025 | Yupelri |
| Arbor Pharmaceuticals, INC. | $69.98 | 2021 | |
| Paratek Pharmaceuticals, INC. | $64.11 | 2024-2025 | Nuzyra |
| Renalytix Ai, INC. | $62.06 | 2023-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Xeris Pharmaceuticals, INC. | $54.88 | 2022-2023 | Gvoke Hypopen |
| Mannkind Corporation | $51.13 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $48.25 | 2019-2023 | Eliquis |
| Idorsia Pharmaceuticals US INC | $46.61 | 2022-2023 | Quviviq |
| Ironshore Pharmaceuticals INC. | $46.22 | 2019-2021 | |
| Shield Therapeutics INC | $46.00 | 2024-2025 | |
| Amphastar Pharmaceuticals, INC. | $40.87 | 2024 | |
| Sanofi-Aventis U.S. LLC | $40.56 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $35.92 | 2019 | |
| Amneal Pharmaceuticals LLC | $35.06 | 2019-2023 | Lyvispah |
| Optinose US, INC. | $34.86 | 2024 | |
| Alkermes, INC. | $34.58 | 2019-2023 | Aristada, Lybalvi |
| Aimmune Therapeutics, INC. | $33.40 | 2025 | Zenpep |
| Endo Pharmaceuticals INC. | $33.23 | 2019 | |
| Corium, LLC | $27.42 | 2023-2024 | Azstarys |
| Medtronic, INC. | $25.05 | 2022 | |
| Grifols USA, LLC | $24.50 | 2023 | Prolastin-C Liquid |
| Ironwood Pharmaceuticals, INC | $23.79 | 2019-2020 | |
| Verona Pharma, INC. | $19.31 | 2025 | Ohtuvayre |
| Insulet Corporation | $18.57 | 2021 | |
| Daiichi Sankyo INC. | $17.18 | 2021 | |
| Azurity Pharmaceuticals, INC. | $17.06 | 2025 | Vivimusta |
| Nestle Healthcare Nutrition INC. | $15.54 | 2022 | |
| Tris Pharma INC | $15.50 | 2023 | Dyanavel Xr |
| Vertical Pharmaceuticals, LLC | $13.77 | 2019 | |
| Bausch Health US, LLC | $13.64 | 2022 | |
| Currax Pharmaceuticals LLC | $13.49 | 2025 | Contrave |
| Alfasigma USA, INC. | $13.47 | 2020 | |
| Corcept Therapeutics | $13.07 | 2024 | Korlym |
| Medtronic Minimed, INC. | $12.81 | 2020 | |
| Evoke Pharma, INC. | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.